Identifying and manipulating synaptically connected neurons across brain regions remains a core challenge in understanding complex nervous systems. RetroLEAP is a novel approach for retrograde trans-synaptic Labelling, Expression And Perturbation. GFP-dependent recombinase (Flp-DOG) detects trans-synaptic transfer of GFP-tetanus toxin heavy chain fusion protein (GFP-TTC) and activates expression of any gene of interest in synaptically connected cells. RetroLEAP overcomes existing limitations, is non-toxic, highly flexible, efficient, sensitive and easy to implement.
Main
To understand complex neuronal circuits, it is essential to precisely identify and manipulate neurons forming synaptically connected networks at different scales, ranging from local to brain-wide circuits.
Traditionally, tracing approaches distinguish anterograde and retrograde tracers. The former refers to labelling via projection targets of neuronal axons and the latter to labelling via synaptic inputs connected to a dendritic tree 1 . Anterograde tracing makes use of fluorescent molecules or genetically expressed fluorophores to visualize axons and hence identify projections to target areas across the nervous system 2 . However, these tracers only allow for the identification of putative input areas, as they do not cross synaptic connections. In contrast, retrograde tracing refers to the labelling of the neuron via its axon, while retrograde trans-synaptic labelling specifically refers to the transfer of the label from the postsynaptic neuron expressing the label (donor cell) to connected presynaptic neurons (acceptor cell) 3 .
Current approaches for retrograde trans-synaptic tracing can be classified into three categories, each based on a different principle. Firstly, tracer proteins like wheat germ agglutinin (WGA) or the non-rAAV-based retrograde trans-synaptic tracing 3 out of 11 toxic heavy chain of the tetanus toxin (TTC) that are able to cross synapses between donor and acceptor cells in a retrograde manner 4, 5 . Secondly, recombinant viruses that cause a secondary infection of the acceptor cell by retrogradely crossing a synapse like herpes simplex virus (HSV), rabies virus (RV) or vesicular stomatitis virus (VSV) 1, 6, 7 . Thirdly, axon terminals can take up cholera toxin subunit B (CtB) or get directly infected with canine associated virus (CAV) or rAAV-retro, a rAAVvariant optimized for axonal uptake [8] [9] [10] .
While some of the mentioned methods are widely used, several caveats restrict their applicability. For instance, viruses that directly infect axonal terminals do not label cells that share a synaptic connection, but merely provide an area-specific retrograde label. Furthermore, viruses as well as trans-synaptic molecules can have cytotoxic effects (RV, HSV, VSV, WGA), their uptake can vary depending on cell type (CAV, HSV), expression strength and labelling intensity are rather low (certain RV-variants, TTC, WGA) or the synaptic transfer may not be limited to a single synapse, causing a 'dilution' effect and uncertainty about first order synaptic connections (TTC, WGA, HSV, VSV, nonpseudotyped RV) 6, 7, [11] [12] [13] [14] [15] .
To overcome these limitations, we combined the retrograde tracer (GFP-TTC 4 ) with a presynaptic amplification mechanism for efficient detection and manipulation of connected cells. The amplification was achieved by expressing a flip-recombinase whose activity is dependent on the presence and binding of GFP (Flp-DOG 16 ) in the acceptor cell. The activated Flp-DOG then drives the expression of fluorescent reporters, actuators, silencers, Cre-recombinase or any other protein of interest. Each of the genetic components is delivered to putatively connected brain regions through stereotactic injection of recombinant rAAVs ( Fig. 1a , Supplementary Fig. 1 ), permitting long-term gene expression with no observable adverse effects on the rAAV infected cells.
To test retroLEAP, we used the well-described cortico-pontine system. In this circuit, neurons from premotor cortex layer 5 send long-range axonal projections to the pontine nuclei of the brain stem rAAV-based retrograde trans-synaptic tracing 4 out of 11 which in turn send projections to the contralateral cerebellum, allowing us to probe both retrograde and anterograde labelling 17, 18 (Fig. 1a ).
For probing the retrograde directionality, we injected rAAVs encoding the retrograde tracer GFP-TTC into the pontine nuclei, receiving layer 5 inputs, and a mixture of two rAAVs encoding Flp-DOG and the flip-dependent reporter FRT-ChR2-mCherry (henceforth referred to as the reporter mix), respectively, into the ipsilateral premotor cortex projecting to Pons (Fig. 1a ). Six weeks after injection, the donor cells in the pontine nuclei and their cerebellar projections strongly expressed GFP-TTC ( Fig.   1b ,d, Supplementary Fig. 2 ). GFP-TTC was detected by Flp-DOG and activated dense mCherry-ChR2 expression in a large number of layer 5 neurons in the premotor cortical area ( Fig. 1c, red) . While the fluorescence intensity and number of both donor and acceptor cells increased between 3 and 6 weeks post injection ( Fig. 1e , f, Supplementary Fig. 2 ), acceptor cells showing Flp-DOG-dependent mCherry expression ( Fig. 1c, Supplementary Fig. 3 ) were confined to layer 5 pyramidal cells in the premotor cortex area that had been injected with the reporter mix ( Fig. 1b, c) . Thus, there is no evidence for second order transfer to neurons locally connected with the acceptor cells. If no GFP-TTC was injected into the pontine nuclei, no mCherry-positive cells could be detected in the premotor cortex, indicating that the observed mCherry-signal was not due to leaky expression ( Supplementary Fig. 3 ). In addition, some acceptor neurons could be identified directly via the retrograde transfer of GFP-TTC ( Fig. 1c , green, Supplementary Fig. 3 ). These labeled neurons are not restricted to the region of interest defined by the reporter mix injection and illustrate that under certain conditions synaptically transferred GFP-TTC can be detected, as reported previously 4 . Noticeably, the GFP-signal in both acceptor and donor cells did not degrade during tissue clearing ( Supplementary Fig. 4 & Supplementary Dataset 1), making retroLEAP suitable for the use of single plane illumination microscopy (SPIM) 11 .
More detailed quantification of the number of labelled cells in layer 5 shows that doubling the expression time from 3 to 6 weeks increased the number of GFP-positive acceptor cells by 1.6 fold rAAV-based retrograde trans-synaptic tracing 5 out of 11 ( Fig. 1f) . In contrast, the number of mCherry-positive cells increased by more than 5 fold, indicating that both the GFP-TTC transfer from donor to acceptor cells as well as the exclusively pre-synaptic GFP-mediated amplification system remain operative in virus-transduced cells many weeks after injection ( Fig. 1f ). It also highlights that the combination with Flp-DOG amplifies the signal in acceptor cells, hence allowing the identification of many more synaptic partners than sole GFP-TTC transfer.
To investigate the possibility of anterograde trans-synaptic GFP-TTC transfer, we injected the reporter mix into the cerebellum (Fig. 1a ). As granule cells of the cerebellum receive inputs from neurons of the pontine nuclei via the mossy fibers, GFP or mCherry-positive cerebellar granule cells would indicate a putative anterograde transmission of GFP-TTC from the pons to the cerebellum 17, 18 .
However, three weeks after GFP-TTC delivery into the pons and despite the strong GFP-signal in the donor cells of the pontine nuclei and in their mossy fiber projections ( Fig. 1b, d, Supplementary Fig.   5 ), we failed to identify mCherry or GFP-positive cerebellar granule cells ( Supplementary Fig. 5f, j) .
On the other hand, we unexpectedly did observe GFP-positive cells within the deep cerebellar nuclei as well as GFP and mCherry-positive Purkinje cells which increased in number with longer expression time ( Supplementary Fig. 5 ). As many targets of the deep cerebellar nuclei, like the red nucleus or the reticular formation, are located in close proximity to the injection site of the virus directing transsynaptic tracer-expression in the pons, it is most likely that cells in these nuclei have been inadvertently co-infected with the GFP-TTC expressing virus, a problem that can be addressed by more limited local injections or by using cell-type specific expression of GFP-TTC.
To test the feasibility of cell-type specific tracer expression, we used the specific expression of Cre in pyramidal neurons of layer 5 in the somatosensory cortex of RBP4-Cre mice 19 . Here we used a Credependent, rAAV-encoded GFP-TTC (GFP-TTC-DIO) to trace the cells projecting from the posteromedial nucleus of the thalamus (POm) onto layer 5 cells in S1 cortex 20 . As expected, the Creinduced GFP-TTC expression was restricted to the donor cells in layer 5 of S1 region in RBP4-Cre mice ( Fig. 2a ) and the POm injected reporter mix was activated in cell bodies in the POm by the retrograde transport of GFP-TTC as indicated by the mCherry signal. In contrast to the cortico-pontine rAAV-based retrograde trans-synaptic tracing 6 out of 11 system, acceptor cells in the POm could not be visualized directly through the uptake of GFP-TTC, highlighting the necessity of a pre-synaptic amplification mechanism ( Fig. 2a ) for synaptic connections that apparently transfer GFP-TTC in a less efficient manner.
Given the high variability of labelling efficiency through direct GFP-TTC transmission, we chose the mitral cell (MC) to piriform cortex (pirCtx) connection (Fig. 2b) , as uniform labelling of MCs has so far been difficult to achieve. In this circuit, the retrograde transport of GFP-TTC from pirCtx neurons to MCs was very effective, illustrated by the strong and early labelling of acceptor cells in the entire mitral cell layer (MCL) (Fig. 2b) which could be detected already one week post injection ( Supplementary   Fig. 6 ). Yet, due to the low spread of the reporter mix in the MCL, we observed only a few mCherrypositive MCs (Fig. 2b) .
In summary, we present a novel combination of two independent systems that allow rAAV-based, cell type-specific, efficient and non-toxic retrograde tracing. This strategy encompasses several attractive features: (1) lack of toxicity, (2) high efficiency in labelling synaptically connected neurons, (3) extensive versatility in controlling gene expression in the presynaptically connected neurons (e.g.
ChR, Cre recombinase, toxins, etc.) and (4) identification of weakly connected acceptor cells in which the levels of transmitted GFP-TTC are too low to be visualized. Thus, as our approach combines the low immunogenicity of rAAVs with the plethora of already existing rAAV-compatible sensors and actuators, it has the potential to become a key technology in the study and manipulation of neuronal networks.
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